APA (7th ed.) Citation

Blix, K., Jensvoll, H., Brækkan, S. K., & Hansen, J. (2013). White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism - The Tromsø Study. PLoS ONE, 8(9), e73447.

Chicago Style (17th ed.) Citation

Blix, Kristine, Hilde Jensvoll, Sigrid Kufaas Brækkan, and John-Bjarne Hansen. "White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism - The Tromsø Study." PLoS ONE 8, no. 9 (2013): e73447.

MLA (9th ed.) Citation

Blix, Kristine, et al. "White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism - The Tromsø Study." PLoS ONE, vol. 8, no. 9, 2013, p. e73447.